Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	RAB6D RAP1A RAP1B ABCB7 KIF27 DNAH10 ABCB6 RAB6B RAB6C ATP10D DHX15 ARL4C ATP2C1 SUPV3L1 DDX53 GNAI1 GNAI3 KIF13A RAB6A DNAH11	1.46e-05	775	174	20	GO:0017111
GeneOntologyMolecularFunction	pyrophosphatase activity	RAB6D RAP1A RAP1B ABCB7 KIF27 DNAH10 ABCB6 RAB6B RAB6C ATP10D DHX15 ARL4C ATP2C1 SUPV3L1 DDX53 GNAI1 GNAI3 KIF13A RAB6A DNAH11	4.48e-05	839	174	20	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	RAB6D RAP1A RAP1B ABCB7 KIF27 DNAH10 ABCB6 RAB6B RAB6C ATP10D DHX15 ARL4C ATP2C1 SUPV3L1 DDX53 GNAI1 GNAI3 KIF13A RAB6A DNAH11	4.56e-05	840	174	20	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	RAB6D RAP1A RAP1B ABCB7 KIF27 DNAH10 ABCB6 RAB6B RAB6C ATP10D DHX15 ARL4C ATP2C1 SUPV3L1 DDX53 GNAI1 GNAI3 KIF13A RAB6A DNAH11	4.56e-05	840	174	20	GO:0016818
GeneOntologyMolecularFunction	GTP binding	RAB6D RAP1A RAP1B SAMHD1 LRRK1 RAB6B RAB6C ARL4C ADSS2 GNAI1 GNAI3 RAB6A	1.96e-04	397	174	12	GO:0005525
GeneOntologyMolecularFunction	beta-adrenergic receptor kinase activity	GRK5 GRK6	4.48e-04	4	174	2	GO:0047696
GeneOntologyMolecularFunction	guanyl ribonucleotide binding	RAB6D RAP1A RAP1B SAMHD1 LRRK1 RAB6B RAB6C ARL4C ADSS2 GNAI1 GNAI3 RAB6A	4.85e-04	439	174	12	GO:0032561
GeneOntologyMolecularFunction	guanyl nucleotide binding	RAB6D RAP1A RAP1B SAMHD1 LRRK1 RAB6B RAB6C ARL4C ADSS2 GNAI1 GNAI3 RAB6A	4.85e-04	439	174	12	GO:0019001
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	ROCK2 CDS1 POLE GRK5 GRK6 DGKQ LRRK1 TIPARP NEK4 PIKFYVE STK11 DGUOK ETNK2 DLG2 EIF2AK4 ATM CTU1 EPHA10 PARP12	5.53e-04	938	174	19	GO:0016772
GeneOntologyMolecularFunction	GTPase activating protein binding	FMNL3 GNAI1 GNAI3	5.69e-04	19	174	3	GO:0032794
GeneOntologyMolecularFunction	G protein-coupled serotonin receptor binding	GNAI1 GNAI3	7.42e-04	5	174	2	GO:0031821
GeneOntologyCellularComponent	G protein-coupled receptor complex	DRD2 GRM1 GPR156	8.75e-05	11	173	3	GO:0097648
GeneOntologyCellularComponent	integrin alphaIIb-beta3 complex	ITGA2B TSPAN32	2.03e-04	3	173	2	GO:0070442
Domain	P-loop_NTPase	TANC2 ATP6V1B1 RAP1A RAP1B ABCB7 KIF27 DNAH10 MTHFD1L ABCB6 SLFN5 LRRK1 RAB6B RAB6C DHX15 ARL4C ADSS2 CHST15 TJP1 SUPV3L1 DGUOK RAD54B DLG2 DDX53 GNAI1 GNAI3 MYO15A KIF13A RAB6A DNAH11	6.84e-10	848	170	29	IPR027417
Domain	-	ATP6V1B1 RAP1A RAP1B ABCB7 DNAH10 MTHFD1L ABCB6 SLFN5 LRRK1 RAB6B RAB6C DHX15 ARL4C CHST15 TJP1 SUPV3L1 DGUOK RAD54B DLG2 DDX53 GNAI1 GNAI3 MYO15A RAB6A DNAH11	1.77e-08	746	170	25	3.40.50.300
Domain	GPCR_3	GRM1 GRM4 GPR158 GPR156	3.51e-05	21	170	4	IPR000337
Domain	7tm_3	GRM1 GRM4 GPR158 GPR156	4.26e-05	22	170	4	PF00003
Domain	G_PROTEIN_RECEP_F3_2	GRM1 GRM4 GPR158 GPR156	4.26e-05	22	170	4	PS00980
Domain	G_PROTEIN_RECEP_F3_3	GRM1 GRM4 GPR158 GPR156	4.26e-05	22	170	4	PS00981
Domain	G_PROTEIN_RECEP_F3_1	GRM1 GRM4 GPR158 GPR156	4.26e-05	22	170	4	PS00979
Domain	G_PROTEIN_RECEP_F3_4	GRM1 GRM4 GPR158 GPR156	4.26e-05	22	170	4	PS50259
Domain	GPCR_3_C	GRM1 GRM4 GPR158 GPR156	4.26e-05	22	170	4	IPR017978
Pathway	REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	RAP1A RAP1B ITGA2B CRK	7.22e-06	15	124	4	M12101
Pathway	REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	RAP1A RAP1B ITGA2B CRK	7.22e-06	15	124	4	MM14961
Pathway	WP_CHEMOKINE_SIGNALING	ROCK2 RAP1A RAP1B GRK5 GRK6 CRK GNAI1 GNAI3 PREX1	1.49e-05	165	124	9	M39400
Pathway	WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION	RAP1A RAP1B DRD2 GRM1 GNAI1	2.82e-05	41	124	5	M39655
Pathway	WP_CHEMOKINE_SIGNALING_PATHWAY	ROCK2 RAP1A RAP1B GRK5 GRK6 CRK GNAI1 GNAI3 PREX1	3.53e-05	184	124	9	MM15943
Pathway	KEGG_CHEMOKINE_SIGNALING_PATHWAY	ROCK2 RAP1A RAP1B GRK5 GRK6 CRK GNAI1 GNAI3 PREX1	4.18e-05	188	124	9	M4844
Pathway	REACTOME_INTEGRIN_SIGNALING	RAP1A RAP1B ITGA2B CRK	8.56e-05	27	124	4	M760
Pathway	REACTOME_INTEGRIN_SIGNALING	RAP1A RAP1B ITGA2B CRK	9.92e-05	28	124	4	MM14958
Pathway	REACTOME_MET_ACTIVATES_RAP1_AND_RAC1	RAP1A RAP1B CRK	1.04e-04	11	124	3	M27776
Pathway	REACTOME_MET_ACTIVATES_RAP1_AND_RAC1	RAP1A RAP1B CRK	1.04e-04	11	124	3	MM15515
Pathway	REACTOME_MET_PROMOTES_CELL_MOTILITY	COL5A2 RAP1A RAP1B CRK	1.31e-04	30	124	4	MM15517
Pathway	PID_FAK_PATHWAY	DOCK1 ROCK2 RAP1A RAP1B CRK	1.66e-04	59	124	5	M281
Pathway	BIOCARTA_MET_PATHWAY	DOCK1 RAP1A RAP1B CRK	1.92e-04	33	124	4	M19358
Pathway	WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING	DOCK1 RAP1A RAP1B CRK	2.16e-04	34	124	4	M39383
Pathway	PID_CXCR4_PATHWAY	RAP1B GRK6 CRK ARR3 GNAI1 GNAI3	2.49e-04	100	124	6	M124
Pathway	WP_INTEGRINMEDIATED_CELL_ADHESION	DOCK1 ROCK2 RAP1A RAP1B ITGA2B CRK	2.77e-04	102	124	6	M39577
Pathway	WP_INTEGRINMEDIATED_CELL_ADHESION	DOCK1 ROCK2 RAP1A RAP1B ITGA2B CRK	2.77e-04	102	124	6	MM15830
Pathway	REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	RAP1A RAP1B ITGA2B	2.80e-04	15	124	3	M1262
Pathway	REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	RAP1A RAP1B ITGA2B	2.80e-04	15	124	3	MM14959
Pathway	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION	RAP1A RAP1B ITGA2B CRK	3.34e-04	38	124	4	MM15456
Pathway	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION	RAP1A RAP1B ITGA2B CRK	3.70e-04	39	124	4	M10735
Pathway	PID_ECADHERIN_NASCENT_AJ_PATHWAY	RAP1A RAP1B CRK TJP1	3.70e-04	39	124	4	M156
Pathway	WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER	DOCK1 RAP1A RAP1B CRK RPTOR ATM	4.17e-04	110	124	6	M48043
Pathway	REACTOME_MET_PROMOTES_CELL_MOTILITY	COL5A2 RAP1A RAP1B CRK	4.49e-04	41	124	4	M27778
Pathway	PID_THROMBIN_PAR1_PATHWAY	ROCK2 AKAP13 GNAI1 GNAI3	5.40e-04	43	124	4	M238
Pathway	REACTOME_ARMS_MEDIATED_ACTIVATION	RAP1A CRK	7.54e-04	5	124	2	MM14671
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DOCK1 CPAMD8 MBTPS1 CDS1 RAP1A ANK3 BLNK NCAM2 ECPAS STEAP2 RAB6B CCNY NIT2 ATP2C1 FAM111A GPR158 TJP1 PTPRS RPTOR LMLN ANKRD17 AKAP13 KDM2A EIF2AK4 MCTP2 THRAP3	3.77e-08	1489	176	26	28611215
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ZNF326 MTHFD1L ACLY POLE URB2 SRBD1 DIS3 SLC2A1 DHX15 USP5 ADSS2 SUPV3L1 RPTOR PIP ANKRD17 NLE1 AKAP13 KDM2A EIF3A PRPF38A DCTN4 SNRPA1 THRAP3 PARP12	9.98e-08	1353	176	24	29467282
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TANC2 ARSJ MTHFD1L PHF12 POLE GRK5 GRK6 DGKQ PANX1 LRRK1 SLC2A1 TBC1D9 PIKFYVE CELSR2 CHST15 PTPRS KCNH2 RPTOR NLE1 AKAP13 PREX1	2.20e-07	1105	176	21	35748872
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	ZNF326 RAP1B KIF27 DNAH10 MTHFD1L ACLY POLE SAMHD1 URB2 GRM1 ECPAS DIS3 SLC2A1 PRDM2 DHX15 ADSS2 SUPV3L1 RPTOR CC2D2A EIF3A ATM SUZ12 SNRPA1 THRAP3	2.57e-07	1425	176	24	30948266
Pubmed	RGS14 is a novel Rap effector that preferentially regulates the GTPase activity of galphao.	RAP1A RAP1B GNAI1 GNAI3	3.04e-07	12	176	4	10926822
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ROCK2 RAP1A RAP1B GRK5 GRK6 SRBD1 OR10G7 PHEX STK11 TBC1D31 IFT88 TJP1 LMLN CC2D2A NLE1 DLG2 PABPC1L GNAI1 EIF3A EIF2AK4 GNAI3 ATM PREX1 THRAP3	3.18e-07	1442	176	24	35575683
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	ROCK2 TPTE ZNF326 MTHFD1L ACLY POLE SAMHD1 ECPAS DIS3 USP5 ATP2C1 PTPRA TJP1 PTPRS ANKRD17 GNAI1 EIF3A GNAI3 SNRPA1	5.87e-07	974	176	19	28675297
Pubmed	Coupling of dopamine receptor subtypes to multiple and diverse G proteins.	DRD2 GNAI1 GNAI3	1.26e-06	5	176	3	10978845
Pubmed	Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin {alpha}(IIb){beta}(3) activation and platelet aggregation.	RAP1B ITGA2B GNAI1	2.52e-06	6	176	3	15863506
Pubmed	Intrinsic planar polarity mechanisms influence the position-dependent regulation of synapse properties in inner hair cells.	GNAI1 GNAI3 MYO15A	2.52e-06	6	176	3	30975754
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	ROCK2 RAP1B ANK3 PANX1 FMNL3 PTPRA PTPRS DLG2 ELMOD3 GNAI3 IL6ST	3.90e-06	377	176	11	38117590
Pubmed	Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles.	DOCK1 RAP1B ECPAS FMNL3 RPTOR GNAI3	6.33e-06	89	176	6	27034005
Pubmed	Inhibitory G proteins play multiple roles to polarize sensory hair cell morphogenesis.	TJP1 GNAI1 GNAI3	1.05e-05	9	176	3	38651641
Pubmed	Toll-like receptors differentially regulate GPCR kinases and arrestins in primary macrophages.	GRK5 GRK6 ARR3	1.05e-05	9	176	3	18180038
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ONECUT2 ABCB7 KMT5A SLFN5 URB2 ONECUT1 SLC2A1 CCNY RETREG3 DHX15 ATP2C1 FAM111A TJP1 RPTOR PIP PTRHD1 UGT8 GNAI3 THRAP3	1.24e-05	1203	176	19	29180619
Pubmed	The LGN protein promotes planar proliferative divisions in the neocortex but apicobasal asymmetric terminal divisions in the retina.	TJP1 GNAI1 GNAI3	1.49e-05	10	176	3	26755700
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	KMT5A DIS3 CRK DHX15 TJP1 RPTOR ANKRD17 THRAP3	1.50e-05	215	176	8	35973513
Pubmed	Crk proteins transduce FGF signaling to promote lens fiber cell elongation.	RAP1A RAP1B CRK TJP1	1.79e-05	31	176	4	29360039
Pubmed	Rap1A and rap1B ras-family proteins are prominently expressed in the nucleus of squamous carcinomas: nuclear translocation of GTP-bound active form.	RAP1A RAP1B	2.55e-05	2	176	2	13679863
Pubmed	Rap1 promotes endothelial mechanosensing complex formation, NO release and normal endothelial function.	RAP1A RAP1B	2.55e-05	2	176	2	25807985
Pubmed	Rap1 Is Essential for B-Cell Locomotion, Germinal Center Formation and Normal B-1a Cell Population.	RAP1A RAP1B	2.55e-05	2	176	2	34140948
Pubmed	Activated heterotrimeric G protein αi subunits inhibit Rap-dependent cell adhesion and promote cell migration.	RAP1A GNAI1	2.55e-05	2	176	2	29259127
Pubmed	Neutrophil-derived glutamate regulates vascular endothelial barrier function.	GRM1 GRM4	2.55e-05	2	176	2	11847215
Pubmed	Rap1B promotes VEGF-induced endothelial permeability and is required for dynamic regulation of the endothelial barrier.	RAP1A RAP1B	2.55e-05	2	176	2	29222111
Pubmed	Enhanced cortico-amygdala efficacy and suppressed fear in absence of Rap1.	RAP1A RAP1B	2.55e-05	2	176	2	18305243
Pubmed	Rab6-Mediated Polarized Transport of Synaptic Vesicle Precursors Is Essential for the Establishment of Neuronal Polarity and Brain Formation.	RAB6B RAB6A	2.55e-05	2	176	2	38830762
Pubmed	Expression of protein-tyrosine phosphatases in the major insulin target tissues.	PTPRA PTPRS	2.55e-05	2	176	2	9357975
Pubmed	Mutation in RAP1 is a rare event in myelodysplastic syndromes.	RAP1A RAP1B	2.55e-05	2	176	2	16118622
Pubmed	Mutation analysis of RAP1 gene in papillary thyroid carcinomas.	RAP1A RAP1B	2.55e-05	2	176	2	18948674
Pubmed	Rab6c, a new member of the rab gene family, is involved in drug resistance in MCF7/AdrR cells.	RAB6C RAB6A	2.55e-05	2	176	2	11054569
Pubmed	Expression of Rap 1 suppresses genomic instability of H-ras transformed mouse fibroblasts.	RAP1A RAP1B	2.55e-05	2	176	2	9330640
Pubmed	Dose-dependent regulation of horizontal cell fate by Onecut family of transcription factors.	ONECUT2 ONECUT1	2.55e-05	2	176	2	32790713
Pubmed	Rap1 GTPase activation and barrier enhancement in rpe inhibits choroidal neovascularization in vivo.	RAP1A RAP1B	2.55e-05	2	176	2	24039860
Pubmed	Gut-derived GIP activates central Rap1 to impair neural leptin sensitivity during overnutrition.	RAP1A RAP1B	2.55e-05	2	176	2	31403469
Pubmed	Ionizing radiation induces ataxia telangiectasia mutated kinase (ATM)-mediated phosphorylation of LKB1/STK11 at Thr-366.	STK11 ATM	2.55e-05	2	176	2	12234250
Pubmed	Role of the small GTPase Rap1 for integrin activity regulation in endothelial cells and angiogenesis.	RAP1A RAP1B	2.55e-05	2	176	2	18805968
Pubmed	Requirement of Gαi1 and Gαi3 in interleukin-4-induced signaling, macrophage M2 polarization and allergic asthma response.	GNAI1 GNAI3	2.55e-05	2	176	2	33754034
Pubmed	The rap GTPases regulate B cell morphology, immune-synapse formation, and signaling by particulate B cell receptor ligands.	RAP1A RAP1B	2.55e-05	2	176	2	18191594
Pubmed	Loss of neuronatin promotes "browning" of primary mouse adipocytes while reducing Glut1-mediated glucose disposal.	SLC2A1 NNAT	2.55e-05	2	176	2	23482445
Pubmed	Chromosome mapping of the human RAS-related RAP1A, RAP1B, and RAP2 genes to chromosomes 1p12----p13, 12q14, and 13q34, respectively.	RAP1A RAP1B	2.55e-05	2	176	2	2108841
Pubmed	Genome-wide CRISPR screens in spheroid culture reveal that the tumor suppressor LKB1 inhibits growth via the PIKFYVE lipid kinase.	PIKFYVE STK11	2.55e-05	2	176	2	38743625
Pubmed	Rap1a null mice have altered myeloid cell functions suggesting distinct roles for the closely related Rap1a and 1b proteins.	RAP1A RAP1B	2.55e-05	2	176	2	18056377
Pubmed	Rap1a is a key regulator of fibroblast growth factor 2-induced angiogenesis and together with Rap1b controls human endothelial cell functions.	RAP1A RAP1B	2.55e-05	2	176	2	18625726
Pubmed	Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection.	GRK5 GRK6	2.55e-05	2	176	2	17786238
Pubmed	The calcium-sensing receptor promotes urinary acidification to prevent nephrolithiasis.	ATP6V1B1 TRPV5	2.55e-05	2	176	2	19470676
Pubmed	Purification and characterization of the 22,000-dalton GTP-binding protein substrate for ADP-ribosylation by botulinum toxin, G22K.	RAP1A RAP1B	2.55e-05	2	176	2	3141412
Pubmed	Role for the regulator of G-protein signaling homology domain of G protein-coupled receptor kinases 5 and 6 in beta 2-adrenergic receptor and rhodopsin phosphorylation.	GRK5 GRK6	2.55e-05	2	176	2	20038610
Pubmed	Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.	ACLY SLC2A1	2.55e-05	2	176	2	25837797
Pubmed	The human genome encodes at least three non-allellic G proteins with alpha i-type subunits.	GNAI1 GNAI3	2.55e-05	2	176	2	2440724
Pubmed	Association analyses of the interaction between the ADSS and ATM genes with schizophrenia in a Chinese population.	ADSS2 ATM	2.55e-05	2	176	2	19115993
Pubmed	The Rap1 small GTPase is a critical mediator of the effects of stress on prefrontal cortical dysfunction.	RAP1A RAP1B	2.55e-05	2	176	2	32651478
Pubmed	Functional role of mGluR1 and mGluR4 in pilocarpine-induced temporal lobe epilepsy.	GRM1 GRM4	2.55e-05	2	176	2	17446080
Pubmed	Increased prevalence of glycoprotein IIb/IIIa Leu33Pro polymorphism in term infants with grade I intracranial haemorrhage.	ITGA2B F5	2.55e-05	2	176	2	16773503
Pubmed	The C-terminal polyproline-containing region of ELMO contributes to an increase in the life-time of the ELMO-DOCK complex.	DOCK1 ELMOD3	2.55e-05	2	176	2	22177965
Pubmed	Phosphoproteomics of the Dopamine Pathway Enables Discovery of Rap1 Activation as a Reward Signal In Vivo.	RAP1A RAP1B	2.55e-05	2	176	2	26804993
Pubmed	Rap1-GTPases control mTORC1 activity by coordinating lysosome organization with amino acid availability.	RAP1A RAP1B	2.55e-05	2	176	2	32184389
Pubmed	A region of the third intracellular loop of the short form of the D2 dopamine receptor dictates Gi coupling specificity.	DRD2 GNAI1	2.55e-05	2	176	2	14581469
Pubmed	Telomere-dependent and telomere-independent roles of RAP1 in regulating human stem cell homeostasis.	RAP1A RAP1B	2.55e-05	2	176	2	30796637
Pubmed	Protein kinase A-dependent phosphorylation of Rap1 regulates its membrane localization and cell migration.	RAP1A RAP1B	2.55e-05	2	176	2	23946483
Pubmed	Rheb binds and regulates the mTOR kinase.	RAP1A RPTOR ATM	2.71e-05	12	176	3	15854902
Pubmed	Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins.	ITGA2B PTAFR TSPAN32 KCNH2 IL9R	2.71e-05	69	176	5	17192395
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ANK3 MCF2L2 ADGRB3 NCAM2 ZNF879 STAT6 PTPRA IFT88 TJP1 SUPV3L1 LGI3 PCSK6 CEP70 BTG3 DLG2 C1S ATM PREX1 RAB6A	3.05e-05	1285	176	19	35914814
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ROCK2 TANC2 RAP1A ANK3 ADGRB3 GRM1 GRM4 CELSR2 GPR158 TJP1 PTPRS RPTOR ANKRD17 DLG2 GNAI1 THRAP3	3.41e-05	963	176	16	28671696
Pubmed	A molecular blueprint at the apical surface establishes planar asymmetry in cochlear hair cells.	TJP1 GNAI1 GNAI3	3.51e-05	13	176	3	24135232
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	RAP1B ABCB7 ANK3 SLFN12 DIS3 SLC2A1 PRDM2 STAT6 STK11 CDK5RAP3 TBC1D31 ANKRD17 EIF2AK4 GNAI3 PRPF38A KIF13A PARP12	3.96e-05	1084	176	17	11544199
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ROCK2 TANC2 ANK3 ACLY NCAM2 GRM1 SLC2A1 DHX15 USP5 PTPRA TJP1 PTPRS RPTOR LGI3 DLG2 GNAI1 EIF3A DCTN4 THRAP3 DNAH11	4.11e-05	1431	176	20	37142655
Pubmed	Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors.	ONECUT2 ONECUT1 TJP1	4.45e-05	14	176	3	16103213
Pubmed	p130Cas: a versatile scaffold in signaling networks.	RAP1A RAP1B ITGA2B	4.45e-05	14	176	3	16581250
Pubmed	Integrins and Src: dynamic duo of adhesion signaling.	RAP1A RAP1B ITGA2B	4.45e-05	14	176	3	16005629
Pubmed	RGS12 polarizes the GPSM2-GNAI complex to organize and elongate stereocilia in sensory hair cells.	TJP1 GNAI3 MYO15A	5.54e-05	15	176	3	36260679
Pubmed	UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex.	RAP1A RAP1B CRK DHX15 USP5 PYGM EIF3A DCTN4	6.95e-05	267	176	8	33417871
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	ROCK2 RAP1B MTHFD1L ECPAS RAB6B DIS3 SLC2A1 DHX15 USP5 CDK5RAP3 ADSS2 TJP1 SUPV3L1 ANKRD17 GNAI1 EIF3A GNAI3 SNRPA1 THRAP3	6.96e-05	1367	176	19	32687490
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	DOCK1 TANC2 ZNF326 ACLY MCF2L2 NCAM2 ECPAS RAB6B CRK ARID3B PIP AKAP13 PRPF38A PREX1 RAB6A	7.11e-05	916	176	15	32203420
Pubmed	Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.	RAP1A RAP1B	7.61e-05	3	176	2	24642466
Pubmed	Rap1 signaling prevents L-type calcium channel-dependent neurotransmitter release.	RAP1A RAP1B	7.61e-05	3	176	2	23616533
Pubmed	Differential regulation of lipopolysaccharide and Gram-positive bacteria induced cytokine and chemokine production in splenocytes by Galphai proteins.	GNAI1 GNAI3	7.61e-05	3	176	2	16962188
Pubmed	Chromosomal mapping of the genes GPRK5 and GPRK6 encoding G protein-coupled receptor kinases GRK5 and GRK6.	GRK5 GRK6	7.61e-05	3	176	2	7789183
Pubmed	The tyrosine phosphatase SHP-1 promotes T cell adhesion by activating the adaptor protein CrkII in the immunological synapse.	RAP1A CRK	7.61e-05	3	176	2	28790195
Pubmed	G Protein-coupled receptor kinases phosphorylate LRP6 in the Wnt pathway.	GRK5 GRK6	7.61e-05	3	176	2	19801552
Pubmed	Rap1 small GTPase is essential for maintaining pulmonary endothelial barrier function in mice.	RAP1A RAP1B	7.61e-05	3	176	2	38010922
Pubmed	Relationships between Rap1b, affinity modulation of integrin alpha IIbbeta 3, and the actin cytoskeleton.	RAP1B ITGA2B	7.61e-05	3	176	2	11994301
Pubmed	Large Extracellular Vesicle-Associated Rap1 Accumulates in Atherosclerotic Plaques, Correlates With Vascular Risks and Is Involved in Atherosclerosis.	RAP1A RAP1B	7.61e-05	3	176	2	32539601
Pubmed	Rab6 family proteins interact with the dynein light chain protein DYNLRB1.	RAB6B RAB6A	7.61e-05	3	176	2	18044744
Pubmed	Preferential Coupling of Dopamine D2S and D2L Receptor Isoforms with Gi1 and Gi2 Proteins-In Silico Study.	DRD2 GNAI1	7.61e-05	3	176	2	31936673
Pubmed	The role of Crk/Dock180/Rac1 pathway in the malignant behavior of human ovarian cancer cell SKOV3.	DOCK1 CRK	7.61e-05	3	176	2	20237902
Pubmed	Dysfunction of the PI3 kinase/Rap1/integrin α(IIb)β(3) pathway underlies ex vivo platelet hypoactivity in essential thrombocythemia.	RAP1A ITGA2B	7.61e-05	3	176	2	23243278
Pubmed	The mitochondrial ATP-binding cassette transporter Abcb7 is essential in mice and participates in cytosolic iron-sulfur cluster biogenesis.	ABCB7 ABCB6	7.61e-05	3	176	2	16467350
Pubmed	DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane.	DOCK1 CRK	7.61e-05	3	176	2	8657152
Pubmed	Human umbilical cord mesenchymal stem cell-derived exosomal miR-214-3p regulates the progression of gallbladder cancer by regulating ACLY/GLUT1.	ACLY SLC2A1	7.61e-05	3	176	2	37747441
Pubmed	Rap1 and its effector RIAM are required for lymphocyte trafficking.	RAP1A RAP1B	7.61e-05	3	176	2	26324702
Pubmed	OC-3, a novel mammalian member of the ONECUT class of transcription factors.	ONECUT2 ONECUT1	7.61e-05	3	176	2	11944891
Pubmed	Differential effects of inhibitory G protein isoforms on G protein-gated inwardly rectifying K+ currents in adult murine atria.	GNAI1 GNAI3	7.61e-05	3	176	2	29342363
Pubmed	Structural basis for small G protein effector interaction of Ras-related protein 1 (Rap1) and adaptor protein Krev interaction trapped 1 (KRIT1).	RAP1A RAP1B	7.61e-05	3	176	2	22577140
Pubmed	Integrins regulate hERG1 dynamics by girdin-dependent Gαi3: signaling and modeling in cancer cells.	KCNH2 GNAI3	7.61e-05	3	176	2	37923359
Pubmed	Analysis of the relationships between ATM and the Rad54 paralogs involved in homologous recombination repair.	RAD54B ATM	7.61e-05	3	176	2	19061978
Pubmed	Differences in the Phosphorylation-Dependent Regulation of Prenylation of Rap1A and Rap1B.	RAP1A RAP1B	7.61e-05	3	176	2	27760305
Pubmed	Identification and characterization of human TIPARP gene within the CCNL amplicon at human chromosome 3q25.31.	TIPARP PARP12	7.61e-05	3	176	2	12851707
Pubmed	An RPTPα/Src family kinase/Rap1 signaling module recruits myosin IIB to support contractile tension at apical E-cadherin junctions.	RAP1A PTPRA	7.61e-05	3	176	2	25631816
Pubmed	GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.	GNAI1 GNAI3	7.61e-05	3	176	2	30836096
Pubmed	Antidepression action of BDNF requires and is mimicked by Gαi1/3 expression in the hippocampus.	GNAI1 GNAI3	7.61e-05	3	176	2	29507199
GeneFamily	Schlafen family	SLFN12 SLFN5	9.58e-04	7	124	2	1110
GeneFamily	G protein-coupled receptors, Class C orphans	GPR158 GPR156	9.58e-04	7	124	2	285
GeneFamily	Glutamate metabotropic receptors\|Protein phosphatase 1 regulatory subunits	GRM1 GRM4	1.27e-03	8	124	2	281
GeneFamily	CUT class homeoboxes and pseudogenes	ONECUT2 ONECUT1	1.63e-03	9	124	2	527
GeneFamily	Proprotein convertase subtilisin/kexin family	MBTPS1 PCSK6	1.63e-03	9	124	2	973
GeneFamily	ATP binding cassette subfamily B	ABCB7 ABCB6	2.46e-03	11	124	2	806
Coexpression	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	RAP1B PANX1 DIS3 SLC2A1 CRK RNF14 SUPV3L1 RAD54B EIF3A RAB6A THRAP3	2.22e-06	272	174	11	M15123
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DOCK1 ROCK2 COL5A2 RAP1A GRK5 TIPARP DHX15 NEK4 PIKFYVE PPP2R5A ATP2C1 PTPRA TBC1D31 ANKRD17 AKAP13 GNAI1 EIF3A SUZ12 RAB6A	4.55e-06	856	174	19	M4500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	RAP1A ZNF326 KMT5A PHF12 CRK PRDM2 CCNY BCO1 TBC1D31 CELSR2 LMLN KDM2A GNAI1 EIF2AK4 GNAI3 PRPF38A	2.29e-05	595	169	16	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5	ROCK2 ABCB7 FHOD3 ECPAS NEK4 CELSR2 PAPPA EIF3A ATM	3.88e-05	204	169	9	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 CPAMD8 ARSJ ANK3 BLNK SYT9 FHOD3 TBC1D9 DLG2 PAPPA	2.93e-09	183	174	10	b5ede5a0048c585b73c00e88aeddbcaf669347b1
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ONECUT2 FAT4 EFCAB6 DNAH10 NCAM2 GRM1 MYO15A USH2A EPHA10 DNAH11	3.09e-09	184	174	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ONECUT2 FAT4 EFCAB6 DNAH10 NCAM2 GRM1 MYO15A USH2A EPHA10 DNAH11	3.09e-09	184	174	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ONECUT2 FAT4 EFCAB6 DNAH10 NCAM2 GRM1 MYO15A USH2A EPHA10 DNAH11	3.09e-09	184	174	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROCK2 COL5A2 RAP1B CRK DHX15 ADSS2 EIF3A GNAI3 RAB6A IL6ST	5.67e-09	196	174	10	151f1a29a91f8b234e9b6ed062666357a2f69128
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 CPAMD8 ARSJ ANK3 BLNK SYT9 FHOD3 DLG2 PAPPA	5.53e-08	187	174	9	e3095455d2f255854f339f6b05fa87852af0700f
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	COL5A2 MTHFD1L GRK5 ADGRB3 NCAM2 SAMHD1 PTPRS C1S PAPPA	7.91e-08	195	174	9	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	Mesenchymal_cells-Osteoblasts\|Mesenchymal_cells / Lineage and Cell class	COL5A2 DCBLD1 FHOD3 FMNL3 PHEX PTPRS KCNH2 PREX1	6.40e-07	183	174	8	d6b52d52fe9a7a6c798947f05420d79fe12e4662
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 ARSJ ANK3 BLNK SYT9 FHOD3 TBC1D9 DLG2	6.95e-07	185	174	8	d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	COL5A2 GRK5 ADGRB3 NCAM2 SAMHD1 PTPRS C1S PAPPA	9.19e-07	192	174	8	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	COL5A2 GRK5 ADGRB3 NCAM2 SAMHD1 PTPRS C1S PAPPA	9.94e-07	194	174	8	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DOCK1 ANK3 SYT9 LGI3 UGT8 DLG2 GNAI1 SEC14L5	9.94e-07	194	174	8	cb0422e7607dbd77204428b7e2c70dfe14a6ca11
ToppCell	facs-Trachea-nan-3m\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROCK2 COL5A2 MBTPS1 CRK TIPARP PTPRA GNAI3 RAB6A	1.12e-06	197	174	8	0353d925ee4b7aefc2c51b5fab873f465cdf9ebc
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	COL5A2 ADGRB3 NCAM2 STEAP2 PTPRS DLG2 C1S PAPPA	1.12e-06	197	174	8	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	TANC2 COL5A2 FAT4 ANK3 NCAM2 STEAP2 DLG2 MCTP2	1.12e-06	197	174	8	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	COL5A2 ADGRB3 NCAM2 STEAP2 PTPRS DLG2 C1S PAPPA	1.16e-06	198	174	8	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	FAT4 ADGRB3 NCAM2 STEAP2 PHEX PTPRS C1S GNAI1	1.25e-06	200	174	8	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	FAT4 ADGRB3 NCAM2 STEAP2 PHEX PTPRS C1S GNAI1	1.25e-06	200	174	8	a510deaada669e690329183e18df02870bd204b3
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FAT4 ADGRB3 NCAM2 STEAP2 PHEX PTPRS C1S GNAI1	1.25e-06	200	174	8	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AADAC ZNF326 LRRK1 ZNF879 MSL2 GNAI1 DNAH11	4.49e-06	168	174	7	d69452e2cfeb74023b5cf3d09064d7dcad0008ec
ToppCell	Control-Lymphoid-pDC\|Control / Condition, Lineage and Cell class	CETP BLNK SLC2A1 PHEX ARL4C PTPRS CCDC152	6.09e-06	176	174	7	5de16ff65476bde8b23322a44e11412e14f1bafe
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_LINC00507_CTXN3\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ONECUT2 COL5A2 GRM1 STEAP2 RAD54B KIF13A EPHA10	6.32e-06	177	174	7	96d639407f79669f3990138793d157b94273581c
ToppCell	Globus_pallidus-Neuronal-Inhibitory\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	DGKQ FHOD3 GRM1 RNF14 ARL4C KCNH2 EPHA10	7.58e-06	182	174	7	04ccfa951eaa31fed6d140edb6c702d49363c5fa
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 ANK3 BLNK SYT9 FHOD3 DLG2 PAPPA	9.70e-06	189	174	7	3a295c215b5c18e7c673f92b7af5be523421682c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 ANK3 BLNK SYT9 FHOD3 DLG2 PAPPA	9.70e-06	189	174	7	fc88c51ace7d883c01617f3f9b5fab70cc91cc09
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 ANK3 SYT9 NCAM2 FHOD3 TBC1D9 DLG2	1.07e-05	192	174	7	0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ANK3 TJP1 LGI3 UGT8 DLG2 GNAI1 SEC14L5	1.07e-05	192	174	7	3ce5dbde41aeb73d49f2c7991d34682f0827fa5a
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	COL5A2 ADGRB3 NCAM2 STEAP2 PHEX PTPRS C1S	1.11e-05	193	174	7	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	COL5A2 GRK5 ADGRB3 NCAM2 PTPRS C1S PAPPA	1.11e-05	193	174	7	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	proximal-3-Hematologic-IGSF21+_Dendritic\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BLNK LRRK1 URB2 F5 TBC1D31 ATM PARP12	1.19e-05	195	174	7	8592d0332bc82a91e173680cfd1afc5ee189b289
ToppCell	COVID-19-Heart-Fib_1\|Heart / Disease (COVID-19 only), tissue and cell type	COL5A2 ARSJ GRK5 ADGRB3 NCAM2 PCSK6 C1S	1.19e-05	195	174	7	f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCell	proximal-Hematologic-IGSF21+_Dendritic\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BLNK LRRK1 URB2 F5 TBC1D31 ATM PARP12	1.19e-05	195	174	7	c48ff83c48342875f06c6c9e7d5bc6084a992848
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL5A2 GRK5 ADGRB3 NCAM2 PTPRS PCSK6 PAPPA	1.19e-05	195	174	7	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	proximal-Hematologic-IGSF21+_Dendritic-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BLNK LRRK1 URB2 F5 TBC1D31 ATM PARP12	1.19e-05	195	174	7	ae9d61011e95f7840cbb154738c79745fd29943e
ToppCell	RA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	MTHFD1L GRK5 ADGRB3 NCAM2 SAMHD1 PTPRS PAPPA	1.23e-05	196	174	7	e8cbda03837f1f26470a9d93aa7fdaa04e08e38a
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	COL5A2 ADGRB3 NCAM2 STEAP2 DLG2 C1S PAPPA	1.27e-05	197	174	7	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	facs-Trachea-3m\|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ROCK2 COL5A2 MBTPS1 CRK PTPRA GNAI3 RAB6A	1.27e-05	197	174	7	e77016d64b1cac9825fec7cfe5071f1567401187
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TANC2 AADAC CDS1 ARSJ ANK3 LGI3 BTG3	1.31e-05	198	174	7	aa80315395cb5dffc25927c8a77cd2037aea8772
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	TANC2 SLFN5 CHST15 TJP1 LMLN PTRHD1 SUZ12	1.31e-05	198	174	7	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CELSR2 TJP1 PTPRS LGI3 UGT8 DLG2 GNAI1	1.35e-05	199	174	7	5d2e85e40b6b52b1809e680b952913d77215b3d0
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CELSR2 TJP1 PTPRS LGI3 UGT8 DLG2 GNAI1	1.35e-05	199	174	7	9dd4b17fb8c70ab9e126b23b72600463f3db832d
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CELSR2 TJP1 PTPRS LGI3 UGT8 DLG2 GNAI1	1.35e-05	199	174	7	6fb5f931e6217142de38c1fffc011e63bda4772b
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CELSR2 TJP1 PTPRS LGI3 UGT8 DLG2 GNAI1	1.35e-05	199	174	7	1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756
ToppCell	facs-Brain_Non-Myeloid-Hippocampus\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACLY NCAM2 PTPRA PCSK6 UGT8 KIF13A RAB6A	1.40e-05	200	174	7	fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SAMHD1 SLFN5 PRDM2 AKAP13 KDM2A EIF3A ATM	1.40e-05	200	174	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 FAT4 ADGRB3 NCAM2 STEAP2 PTPRS PAPPA	1.40e-05	200	174	7	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	GRK6 PANX1 PTAFR NEK4 STK11 TBC1D31 CHST15	1.40e-05	200	174	7	f11ae9055e72c938b6c9e52701478b2eee681ac4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ANK3 DMRT2 LGI3 UGT8 DLG2 GNAI1 SEC14L5	1.40e-05	200	174	7	829978708463a7459fe1041bd90196775bc4b531
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SAMHD1 SLFN5 F5 ARL4C PTPRA IL6ST	2.77e-05	150	174	6	c922dbb4c9c12ccf08bd5f6168b20606c605d052
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	ZNF326 BLNK CEP70 AKAP13 PRPF38A THRAP3	4.26e-05	162	174	6	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAT4 MCF2L2 ABCB6 DIS3 RETREG3 C1S	5.05e-05	167	174	6	b742558ca92985db0a67c88f530bc375f3d3bb98
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	POLE SLFN5 ONECUT1 ZNF879 TJP1 RPTOR	5.05e-05	167	174	6	774f3264318b002d0df5d06d41d645366038d0bf
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_E\|368C / Donor, Lineage, Cell class and subclass (all cells)	ZNF326 MCF2L2 TSPAN32 RPTOR PABPC1L GNAI1	5.39e-05	169	174	6	0d96c0b4fd26fbc0bf44ff7bed2936eebcc55b74
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL5A2 FAT4 SAMHD1 C1S PAPPA IL6ST	5.39e-05	169	174	6	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	RA-01._Fibroblast_I\|RA / Chamber and Cluster_Paper	COL5A2 MTHFD1L ADGRB3 NCAM2 SAMHD1 PTPRS	5.39e-05	169	174	6	6373562ab3b1765060212a6a53d6543e7e942e80
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB3 SAMHD1 LRRK1 FMNL3 PHEX PTPRS	5.76e-05	171	174	6	af1c93eb75f45c042ea475d93db56e4da207e31f
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	DGKQ GRM1 STEAP2 RNF14 KCNH2 EPHA10	6.14e-05	173	174	6	7e3897868dd3f6e4974f593c60649a543ffc8693
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_4\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	AADAC DCBLD1 STEAP2 DNAJC28 PTPRS LGI3	6.14e-05	173	174	6	ef8d720b99470fe1953661f6e66bc0366266bdb6
ToppCell	Control-Myeloid-pDC\|Control / Disease group,lineage and cell class （2021.01.30）	BLNK SLC2A1 PHEX ARL4C PTPRS CCDC152	6.75e-05	176	174	6	baa3563973ea1a351fe028f55828463d2a51bf1a
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	COL5A2 AADAC FAT4 STEAP2 PCSK6 PAPPA	6.97e-05	177	174	6	3d955ea938a1d2fb1b6d68d4997fd454bd632dfc
ToppCell	Ciliated_cells-A-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	EFCAB6 DNAH10 DCDC2B PIP VWA3B DNAH11	7.19e-05	178	174	6	255473ee6df8a13079fb3bb61038162a40cb4c2c
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RAP1B ANK3 BLNK FHOD3 TBC1D9 PAPPA	7.41e-05	179	174	6	d3438fed0d85d5ed5afa8ff820c45143d77b6c0d
ToppCell	LA-01._Fibroblast_I\|LA / Chamber and Cluster_Paper	COL5A2 GRK5 ADGRB3 NCAM2 PTPRS PCSK6	7.41e-05	179	174	6	dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	POLE SLFN12 RAB6B TIPARP C1S ATM	7.88e-05	181	174	6	274c0b768925cd5804483303f8c5ebd17a534c41
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-5\|TCGA-Colorectal / Sample_Type by Project: Shred V9	CDS1 ARSJ ATP2C1 UGT8 MCTP2 EPHA10	7.88e-05	181	174	6	8fcc9e77fee7c248df26b6c59b10e672242e2084
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 BLNK FHOD3 TBC1D9 DLG2 PAPPA	7.88e-05	181	174	6	aa233b652921848af2257cc3687a7a09c3acfb67
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MORC1 SAMHD1 SLFN5 ARL4C GNAI1 IL6ST	8.12e-05	182	174	6	b86690c109cdc16844a6cd2216c1bf2bf28efd45
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	EFCAB6 DNAH10 DCDC2B CC2D2A VWA3B DNAH11	8.89e-05	185	174	6	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	COL5A2 STEAP2 PTPRS DLG2 C1S PAPPA	8.89e-05	185	174	6	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 CPAMD8 ARSJ BLNK DMRT2 TRPV5	8.89e-05	185	174	6	3d73b3e0bceb192257e5cfbe64b7ccb379b6e22d
ToppCell	5'-Adult-LargeIntestine-Neuronal-Glial_mature\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL5A2 ANK3 ADGRB3 NCAM2 SAMHD1 PAPPA	8.89e-05	185	174	6	f607b6ee579562e2f92103fa5c7053df0170a229
ToppCell	5'-Adult-LargeIntestine-Neuronal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL5A2 ANK3 ADGRB3 NCAM2 SAMHD1 PAPPA	8.89e-05	185	174	6	317f2c854f00aa5957319b818c85eeed7d72ec7f
ToppCell	5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL5A2 ANK3 ADGRB3 NCAM2 SAMHD1 PAPPA	8.89e-05	185	174	6	7bb8fdfe04f85d25056380ec58222366de323a21
ToppCell	Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RAP1B SLFN5 ARL4C TBC1D31 ATM MCTP2	9.16e-05	186	174	6	fc0b488c201a32d829047b58460297df2818b45d
ToppCell	Ciliated_cells-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	EFCAB6 DNAH10 DCDC2B PIP VWA3B DNAH11	9.16e-05	186	174	6	f72267d533fd0c5280d9741ceee3dd116300a7e4
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TANC2 ANK3 MTHFD1L CEP70 DLG2 MCTP2	9.16e-05	186	174	6	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	COL5A2 ADGRB3 NCAM2 STEAP2 PTPRS PAPPA	9.43e-05	187	174	6	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	COVID-19-kidney-CD-PC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANK3 BLNK FHOD3 SLC2A1 PAPPA TRPV5	9.71e-05	188	174	6	8f9996c3f3b27efaaae8960a66af77412de9c7ef
ToppCell	10x5'v1-week_17-19-Hematopoietic\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	RAP1B ITGA2B TSPAN32 RAB6B KCNH2 SEC14L5	9.71e-05	188	174	6	c00ba0abd0c7bb2c8f9166a2ac6220aae4f4d857
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANK3 SAMHD1 SLFN5 ARL4C ATM IL6ST	1.00e-04	189	174	6	9ab77c6fcb573854da5922412f53d2168bda6b58
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANK3 SAMHD1 SLFN5 ARL4C ATM IL6ST	1.00e-04	189	174	6	5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 TIPARP ETNK2 CEP70 AKAP13 SLC5A12	1.00e-04	189	174	6	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL5A2 ADGRB3 PHEX PTPRS C1S PAPPA	1.00e-04	189	174	6	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 ANK3 BLNK SYT9 DMRT2 PAPPA	1.00e-04	189	174	6	532aaf02b364c5c4f58a2021c7c21d86df3875c9
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	COL5A2 NCAM2 STEAP2 PTPRS C1S PAPPA	1.03e-04	190	174	6	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 BLNK FHOD3 PTAFR TBC1D9 TRPV5	1.03e-04	190	174	6	4836ea19308d2a96694f12ab0653b7ce7b101d2f
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL5A2 MTHFD1L LRRK1 STEAP2 C1S PAPPA	1.03e-04	190	174	6	0fea33f2dc1efa23aaa2da1c318482a52a313ff1
ToppCell	Fetal_29-31_weeks-Immune-natural_killer_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TSPAN32 ARL4C TBC1D31 ATM MCTP2 PREX1	1.06e-04	191	174	6	5696e2e2db7b898a1c7ab3582ae74cb712dd5bdf
ToppCell	Control-pDC\|Control / Disease condition and Cell class	BLNK SLC2A1 FMNL3 PHEX PTPRS CCDC152	1.06e-04	191	174	6	543e1437a52d04436862dd1c27b4fae95c44fcc8
ToppCell	Control-pDC-\|Control / Disease condition and Cell class	BLNK SLC2A1 FMNL3 PHEX PTPRS CCDC152	1.06e-04	191	174	6	1d7b0fae4d114d6db933c18b4eb2066ffa61356d
ToppCell	Children_(3_yrs)-Immune-natural_killer_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TSPAN32 ARL4C TBC1D31 ATM MCTP2 PREX1	1.06e-04	191	174	6	9b8b64a36e27a2523b8730c7922fd7ad865a021e
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL5A2 GRK5 ADGRB3 NCAM2 PCSK6 C1S	1.06e-04	191	174	6	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL5A2 GRK5 ADGRB3 NCAM2 PTPRS PCSK6	1.06e-04	191	174	6	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL5A2 FAT4 ADGRB3 NCAM2 STEAP2 PTPRS	1.06e-04	191	174	6	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 ANK3 BLNK TBC1D9 DMRT2 PAPPA	1.09e-04	192	174	6	40f44ac4ab673ee6156abdd2074a60b9de3281ad
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 FHOD3 ANKRD17 DLG2 AKAP13 SLC5A12	1.09e-04	192	174	6	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	15-Trachea-Epithelial-Multiciliated_cell\|Trachea / Age, Tissue, Lineage and Cell class	CDS1 DNAH10 DCDC2B CC2D2A VWA3B DNAH11	1.12e-04	193	174	6	aa3acc7571405169efb656d214f3a8cbf988362e
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL5A2 GRK5 ADGRB3 NCAM2 PHEX PTPRS	1.12e-04	193	174	6	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	COL5A2 FAT4 STEAP2 DLG2 C1S PAPPA	1.12e-04	193	174	6	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	COVID-19-kidney-CD-PC\|kidney / Disease (COVID-19 only), tissue and cell type	TANC2 ANK3 BLNK SLC2A1 PAPPA TRPV5	1.12e-04	193	174	6	738689d009e4b118d7ce3171a207294b95cbe78b
Drug	Debrisoquin sulfate [581-88-4]; Up 200; 9uM; HL60; HG-U133A	ROCK2 ANK3 GRK5 GRK6 TSPAN32 GRM4 RAB6B CELSR2 KDM2A PARP12	2.80e-06	197	173	10	1591_UP
Drug	Sulindac [38194-50-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A	ECPAS PRDM2 PHEX ARL4C ARR3 ETNK2 NLE1 KDM2A NNAT KIF13A	2.80e-06	197	173	10	1693_UP
Drug	guanine	DOCK1 RAP1A RAP1B DRD2 GRK5 GRK6 MCF2L2 GRM1 CRK STK11 ARL4C ADSS2 DGUOK LMLN UGT8 AKAP13 GNAI1 GNAI3 NNAT PREX1 RAB6A	5.28e-06	902	173	21	CID000000764
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	ROCK2 TBC1D9 CRK PRDM2 NEK4 CHST15 TJP1 RAD54B AKAP13	1.15e-05	183	173	9	7498_DN
Drug	Ajmaline [4360-12-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A	ONECUT2 BLNK ATP10D BCO1 DNAJC28 KCNH2 PCSK6 ATM NNAT	1.76e-05	193	173	9	2899_UP
Drug	Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A	ONECUT2 DRD2 GRK5 ECPAS RAB6B KCNH2 PIP ATM IL6ST	1.91e-05	195	173	9	5265_UP
Drug	Nicergoline; Down 200; 8.2uM; PC3; HT_HG-U133A	POLE GRK6 ATP10D PRDM2 USP5 ANKRD17 AKAP13 KDM2A EIF3A	1.99e-05	196	173	9	2058_DN
Drug	Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; HL60; HT_HG-U133A	GRK5 LRRK1 URB2 ECPAS ATP2C1 PTPRA TJP1 PCSK6 NLE1	1.99e-05	196	173	9	2331_UP
Disease	Deoxyguanosine Kinase Deficiency	SAMHD1 DGUOK	3.38e-05	2	172	2	C3711385
Disease	retinal degeneration (implicated_via_orthology)	RAB6D RAB6B RAB6C RAB6A	4.00e-05	33	172	4	DOID:8466 (implicated_via_orthology)
Disease	Kabuki make-up syndrome	RAP1A RAP1B	2.01e-04	4	172	2	C0796004
Disease	Stomach Carcinoma	POLE STK11 ATM	2.40e-04	21	172	3	C0699791
Disease	activating signal cointegrator 1 complex subunit 1 measurement	GRK6 PIKFYVE	3.34e-04	5	172	2	EFO_0801340
Disease	chronotype measurement, sun exposure measurement	ARSJ UGT8	3.34e-04	5	172	2	EFO_0008328, EFO_0010729
Disease	partial thromboplastin time	GRK6 F5 C1S	3.60e-04	24	172	3	EFO_0004310
Disease	azoospermia (implicated_via_orthology)	DMRT2 PTPRS SNRPA1	5.14e-04	27	172	3	DOID:14227 (implicated_via_orthology)
Disease	Parkinson's disease (biomarker_via_orthology)	DRD2 GRK5 GRK6	7.04e-04	30	172	3	DOID:14330 (biomarker_via_orthology)
Disease	heart conduction disease (implicated_via_orthology)	PHEX KCNH2 ETNK2	8.53e-04	32	172	3	DOID:10273 (implicated_via_orthology)
Disease	Colorectal Carcinoma	CPAMD8 MTHFD1L POLE MCF2L2 SYT9 ABCB6 GRM1 F5 STK11 PTPRS KDM2A IL6ST	8.92e-04	702	172	12	C0009402
Disease	McCune Albright syndrome (implicated_via_orthology)	GNAI1 GNAI3	9.24e-04	8	172	2	DOID:1858 (implicated_via_orthology)
Disease	endometrial cancer (implicated_via_orthology)	POLE STK11	9.24e-04	8	172	2	DOID:1380 (implicated_via_orthology)
Disease	cholesteryl esters to total lipids in very large HDL percentage	CETP MSL2 CELSR2	1.21e-03	36	172	3	EFO_0022257
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	KIF27 DNAH10 CETP DGKQ MSL2 CELSR2 PCSK6	1.22e-03	276	172	7	EFO_0004612, EFO_0020943
Disease	Cataract	CPAMD8 SLC2A1 ATM	1.31e-03	37	172	3	C0086543
Disease	hemorrhoid	COL5A2 DCBLD1 SRBD1 PAPPA MYO15A	1.74e-03	147	172	5	EFO_0009552
Disease	anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine	FHOD3 FMNL3	1.79e-03	11	172	2	EFO_0803358, EFO_0803362
Disease	vascular endothelial growth factor D measurement	GRK6 PCSK6	1.79e-03	11	172	2	EFO_0010575
Disease	autosomal dominant nonsyndromic deafness (is_implicated_in)	ELMOD3 EPHA10	1.79e-03	11	172	2	DOID:0050564 (is_implicated_in)
Disease	quality of life during menstruation measurement, acne	FHOD3 FMNL3	1.79e-03	11	172	2	EFO_0003894, EFO_0009366
Disease	osteoarthritis	DNAH10 KMT5A NCAM2 SRBD1 PRDM2 DLG2	1.98e-03	222	172	6	MONDO_0005178
Disease	cholesteryl esters to total lipids in small HDL percentage	CETP CELSR2 PCSK6	2.02e-03	43	172	3	EFO_0022254
Disease	granulins measurement	ITGA2B CELSR2	2.15e-03	12	172	2	EFO_0008141
Disease	phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement	CETP DGKQ MSL2 NEK4 CELSR2 PCSK6 DNAH11	2.24e-03	307	172	7	EFO_0004612, EFO_0020946
Disease	optic disc area measurement	ARSJ F5 UGT8	2.31e-03	45	172	3	EFO_0006937
Disease	Gastric Adenocarcinoma	GRK6 ATM EPHA10	2.31e-03	45	172	3	C0278701
Disease	small vessel stroke	FAT4 ONECUT1 ARL4C DLG2	2.44e-03	96	172	4	EFO_1001504
Disease	transmembrane protein 87B measurement	GRK6 PCSK6	2.53e-03	13	172	2	EFO_0802158
Disease	T-cell surface glycoprotein CD3 epsilon chain measurement	F5 PIKFYVE	2.53e-03	13	172	2	EFO_0802114
Disease	Alzheimer disease, dementia, family history of Alzheimer’s disease	DCBLD1 FHOD3 FMNL3	2.78e-03	48	172	3	EFO_0009268, MONDO_0001627, MONDO_0004975
Disease	blood cobalt measurement	F5 RPTOR CC2D2A USH2A	2.93e-03	101	172	4	EFO_0007577
Disease	Tobacco Dependence	DRD2 RPTOR	2.94e-03	14	172	2	C0040332
Disease	Nicotine Dependence	DRD2 RPTOR	2.94e-03	14	172	2	C0028043
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	CELSR2 ANKRD17	2.94e-03	14	172	2	EFO_0004611, EFO_0008589
Disease	Nicotine Use Disorder	DRD2 RPTOR	2.94e-03	14	172	2	C0376384
Disease	cholesteryl esters to total lipids in small VLDL percentage	CETP CELSR2 PCSK6	2.95e-03	49	172	3	EFO_0022256
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	KIF27 DNAH10 CETP MSL2 CELSR2 PCSK6	3.10e-03	243	172	6	EFO_0004612, EFO_0020944
Disease	cholesterol to total lipids in small HDL percentage	CETP CELSR2 PCSK6	3.30e-03	51	172	3	EFO_0022240
Disease	cholesterol to total lipids in small VLDL percentage	CETP CELSR2 PCSK6	3.30e-03	51	172	3	EFO_0022242
Disease	Hypertriglyceridemia	CETP CELSR2	3.37e-03	15	172	2	C0020557
Disease	melanoma	FAT4 DCBLD1 STK11 DLG2 ATM SUZ12	3.43e-03	248	172	6	C0025202
Disease	urate measurement, bone density	ATP6V1B1 MTHFD1L ADGRB3 TIPARP CEP70 DLG2 VWA3B EIF2AK4 USH2A DNAH11	3.55e-03	619	172	10	EFO_0003923, EFO_0004531
Disease	Tremor, Rubral	ABCB7 SLC2A1	3.84e-03	16	172	2	C0750940
Disease	Ataxia, Appendicular	ABCB7 SLC2A1	3.84e-03	16	172	2	C0750937
Disease	Ataxia, Motor	ABCB7 SLC2A1	3.84e-03	16	172	2	C0278161
Disease	interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement	F5 PCSK6	3.84e-03	16	172	2	EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293
Disease	idiopathic scoliosis (implicated_via_orthology)	MBTPS1 DNAH10	3.84e-03	16	172	2	DOID:0060250 (implicated_via_orthology)
Disease	Ataxia, Sensory	ABCB7 SLC2A1	3.84e-03	16	172	2	C0240991
Disease	Blood Coagulation Disorders	COL5A2 F5	3.84e-03	16	172	2	C0005779
Disease	Abnormal coordination	ABCB7 SLC2A1	3.84e-03	16	172	2	C0520966
Disease	Ataxia, Truncal	ABCB7 SLC2A1	3.84e-03	16	172	2	C0427190
Disease	corneal topography	LRRK1 TJP1 AKAP13 EIF2AK4	3.86e-03	109	172	4	EFO_0004345
Disease	triglycerides in medium VLDL measurement	DNAH10 CETP CELSR2	4.09e-03	55	172	3	EFO_0022155
Disease	response to tenofovir, creatinine clearance measurement	DCBLD1 FHOD3 FMNL3 PREX1	4.25e-03	112	172	4	EFO_0007934, EFO_0009279
Disease	Benign neoplasm of stomach	POLE ATM	4.34e-03	17	172	2	C0153943
Disease	Tactile Amnesia	GNAI1 GNAI3	4.34e-03	17	172	2	C0750906
Disease	Amnestic State	GNAI1 GNAI3	4.34e-03	17	172	2	C0750907
Disease	Dissociative Amnesia	GNAI1 GNAI3	4.34e-03	17	172	2	C0236795
Disease	Neoplasm of uncertain or unknown behavior of stomach	POLE ATM	4.34e-03	17	172	2	C0496905
Disease	Hysterical amnesia	GNAI1 GNAI3	4.34e-03	17	172	2	C0233750
Disease	Temporary Amnesia	GNAI1 GNAI3	4.34e-03	17	172	2	C0233796
Disease	Carcinoma in situ of stomach	POLE ATM	4.34e-03	17	172	2	C0154060
Disease	Amnesia	GNAI1 GNAI3	4.34e-03	17	172	2	C0002622
Disease	alpha-L-iduronidase measurement	RNF212 DGKQ	4.34e-03	17	172	2	EFO_0020139
Disease	Global Amnesia	GNAI1 GNAI3	4.34e-03	17	172	2	C0262497
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	CETP CELSR2	4.34e-03	17	172	2	EFO_0022232
Disease	triglycerides to total lipids in small VLDL percentage	CETP CELSR2 PCSK6	4.75e-03	58	172	3	EFO_0022338
Disease	progression free survival, ovarian carcinoma	FHOD3 FMNL3	4.86e-03	18	172	2	EFO_0001075, EFO_0004920
Disease	very low density lipoprotein cholesterol measurement, esterified cholesterol measurement	CETP CELSR2	4.86e-03	18	172	2	EFO_0008317, EFO_0008589
Disease	adverse effect, response to xenobiotic stimulus	FHOD3 FMNL3 VWA3B	4.98e-03	59	172	3	EFO_0009658, GO_0009410
Disease	hydrocephalus (implicated_via_orthology)	KIF27 CELSR2	5.41e-03	19	172	2	DOID:10908 (implicated_via_orthology)
Disease	sodium-coupled monocarboxylate transporter 1 measurement	CETP CELSR2	5.41e-03	19	172	2	EFO_0802076
Disease	blood nickel measurement	F5 RPTOR KIF13A USH2A	5.42e-03	120	172	4	EFO_0007583
Disease	red blood cell density measurement	ARSJ DNAH10 TSPAN32 PCSK6 UGT8 CC2D2A AKAP13 KDM2A EIF2AK4 MYO15A PREX1 SMIM19	5.64e-03	880	172	12	EFO_0007978
Disease	Schizophrenia	DRD2 ANK3 GRK6 ETNPPL GRM1 GRM4 PTPRA ADSS2 KCNH2 DLG2 ATM MCTP2	5.79e-03	883	172	12	C0036341
Disease	lymphocyte percentage of leukocytes	KMT5A GRK5 SAMHD1 LRRK1 TSPAN32 SLC2A1 CRK MSL2 STK11 PREX1	5.82e-03	665	172	10	EFO_0007993

Protein segments in the cluster

Peptide	Gene	Start	Entry
VFQTYAKLRQVPRLF	URB2	456	Q14146
REAQFLYAQKLVTQP	ARID3B	36	Q8IVW6
KVIQTAFQRASYPDI	CETP	46	P11597
RQQKVIPVVNSFYAA	ELMOD3	276	Q96FG2
YRLKFNEFVNTVPTI	ARL4C	31	P56559
PFLKAVLRQERVSLY	CDS1	336	Q92903
YAVKRIPINPASRQF	EIF2AK4	616	Q9P2K8
FNNILVRVYVPKRKS	AADAC	86	P22760
LQYDKNFIQIRRVFP	ADGRB3	121	O60242
VITFVRYNDTPIVKA	GRM4	606	Q14833
QAVPIETRRYALKNV	FAT4	1501	Q6V0I7
VTQRITKYPVLFQRI	AKAP13	2146	Q12802
YFRVTLLKATPVQVD	DGKQ	876	P52824
LQARKPVQIFERSVY	DGUOK	131	Q16854
KFYNTPARVIVLLQE	DNAH11	376	Q96DT5
RALNVLVPIFYRNIV	ABCB6	276	Q9NP58
PEQKQIYRFVRTLFS	CCNY	166	Q8ND76
APQFSEKRYVVQVRE	CELSR2	396	Q9HCU4
VVRYLVKEVNQFPSD	ANKRD17	1401	O75179
FAKQKVYNPRIRVES	DHX15	441	O43143
KRSRFQFLYDVQVPI	MTHFD1L	851	Q6UB35
QFLYDVQVPIVDKIR	MTHFD1L	856	Q6UB35
FRKDLYVQTLQVVPA	ARR3	71	P36575
QLSQIVPKVAVFYRA	ATP2C1	606	P98194
FASDPIKIVRAQRQY	ETNPPL	26	Q8TBG4
KVIVSLQYPQDLRAR	ARMC12	311	Q5T9G4
IRTTKYTLLNFVPRN	ATP10D	76	Q9P241
RVIQKRVPNAYDKTA	CRK	241	P46108
FILRRTQEIINKYLP	RAD54B	526	Q9Y620
EIFYDLVRQINRKTP	RAP1A	156	P62834
EIFYDLVRQINRKTP	RAP1B	156	P61224
NPFIYSLRNKEVISV	OR5K2	286	Q8NHB8
YNVKQLFRRVAAALP	RAB6A	161	P20340
YNVKQLFRRVASALP	RAB6B	161	Q9NRW1
YNVKQLFRRVAAALP	RAB6C	161	Q9H0N0
YNVKQLFRRVAAALP	RAB6D	161	Q53S08
NYIPTQQDVLRTRVK	GNAI1	166	P63096
PEFKYRILQILRVQN	TIPARP	486	Q7Z3E1
IDVEKPLNSFQYQRR	MORC1	461	Q86VD1
LFNPVVYTLRNKEVK	OR10G7	281	Q8NGN6
FLSRVPSDVQKVQYA	MCTP2	846	Q6DN12
IVKEYRNQFPEILRR	MAGEE1	521	Q9HCI5
TQQNRKLTDFYPVRR	KMT5A	216	Q9NQR1
PIARSEVFRYSLQKL	NNAT	46	Q16517
VTPQRKVFRSLKYAE	MBTPS1	126	Q14703
NYIPTQQDVLRTRVK	GNAI3	166	P08754
KVTILELFRSPAYRQ	SLC2A1	256	P11166
ESYAVRKNEFPVIVR	LRRK1	181	Q38SD2
ELLRDFPRQKSYFIV	MYO15A	2291	Q9UKN7
VLKVFLSRTAQRIPY	GPR158	506	Q5T848
RRLSQFNKTAVPVRY	ARSJ	521	Q5FYB0
PQAISYLEKTFQVRR	LMLN	121	Q96KR4
RYRTISKIPQITLNF	KCNH2	326	Q12809
ASYLIKPEVQVRQVA	ECPAS	486	Q5VYK3
DLIRFKPSQRQIYLF	MCF2L2	861	Q86YR7
VTPREVQRLYVQVNK	ETNK2	321	Q9NVF9
PVEIRTILFRYFNKV	KIF27	1106	Q86VH2
RVKRQVRSDPQALYF	PCSK6	146	P29122
NPLIYSLRNKEVFRA	OR2M4	286	Q96R27
YIQIFITVFRLPQKE	OR52A1	221	Q9UKL2
TVLQIKVYRDFINIP	PDZD9	101	Q8IXQ8
LRQPYIKRQISFFLE	NEK4	256	P51957
KRYSIPQAIFAQRVL	ONECUT1	306	Q9UBC0
LKRYSIPQAIFAQRV	ONECUT2	346	O95948
SQYFPDSVIVKNIRQ	DNAJC28	176	Q9NX36
QRIQTRPYLFEQVAK	FAM161B	541	Q96MY7
FDKIFVPQVREYLRS	JRKL	266	Q9Y4A0
SIPRVFYVNQRVAKA	POLE	1361	Q07864
VTNLKPATRYVFQIR	EPHA10	516	Q5JZY3
RQTDVRVTKFKAPQY	ODF3	186	Q96PU9
SFRQPKVVRYRVVNL	PAPPA	346	Q13219
VVYTLFVPFRQKTDV	PANX1	291	Q96RD7
RALEFTNIYVKNLPV	PABPC1L	186	Q4VXU2
KAFTEINRLLPYFRQ	MSL2	26	Q9HCI7
RYVLFVLAVLQKSEP	PTPRS	1241	Q13332
LPFYFVQKIERVQNL	PARP12	521	Q9H0J9
RYLLVRTPKTFAEAQ	PRG3	111	Q9Y2Y8
KNYVQRIVDVRPTLV	PIKFYVE	736	Q9Y2I7
PERAIFQIKQYNSVS	ATM	2271	Q13315
QYFERASLIQPTQVK	IFT88	641	Q13099
VQDLKPFTEYVFRIR	IL6ST	286	P40189
IYNIEDRTRVPNKFR	KDM2A	311	Q9Y2K7
VVFFNKRVYNIPVRF	BLNK	386	Q8WV28
KRVYNIPVRFIEATK	BLNK	391	Q8WV28
LRSQEVPEFRNYKQV	CC2D2A	916	Q9P2K1
QAQFYENIVKVIRPK	DOCK1	1321	Q14185
VNEVQRFEYSRPIRK	DOCK1	1431	Q14185
NFERKAVYQRQVRAP	DMRT2	186	Q9Y5R5
AVYQRQVRAPSLLAK	DMRT2	191	Q9Y5R5
VTQNRVFAYLCKRVP	CEP70	191	Q8NHQ1
RFNVLQYVVPEVKDL	EIF3A	376	Q14152
LDTFVYQIPRRIFIQ	EFCAB6	326	Q5THR3
RIKPSAFYARPQQTI	DCDC2B	256	A2VCK2
VLREQIVAQYPSLKR	FAM111A	291	Q96PZ2
PVFVRFIRSYKEAEQ	FMNL3	916	Q8IVF7
RPLQFASQKEVVLYA	CTU1	211	Q7Z7A3
SKVPDEVRQRYINLF	LINC00032	36	P0C843
SPRYVDRVTEFLQQK	CDK5RAP3	426	Q96JB5
FIQTDKPVYRPQHRV	CPAMD8	131	Q8IZJ3
EALVKVINNPSYRQR	UGT8	411	Q16880
PYAIREVNINKFCRI	FHOD3	1231	Q2V2M9
PAKAKYVFRDVVQIT	C1S	306	P09871
VLPQSIYRRKLQHFQ	CCDC152	206	Q4G0S7
RLVQPFEDNIKISVY	ADGRF2	161	Q8IZF7
IQESKLPVYQVFARE	ANK3	2751	Q12955
VFEYRTQNVARLPII	COL5A2	1461	P05997
YKVFTQRVPDKRVII	GPR156	146	Q8NFN8
AFQQYPDLLKSIIRV	DDX53	226	Q86TM3
IKRLQVAQLYPIAIF	DLG2	781	Q15700
VNPIIYTTFNIEFRK	DRD2	421	P14416
NNFIPPIVARYVRVV	DCBLD1	381	Q8N8Z6
KLYRQNIVLNRPFSI	FAM217A	471	Q8IXS0
LERQPVTKNTFRQYR	GRK5	176	P34947
LERQPVTKNTFRQYR	GRK6	176	P43250
YIIIAKPERNVRSAF	GRM1	836	Q13255
FKIQLVAVNYIPEVR	DCTN4	296	Q9UJW0
NTYLTKAFQQRDPRI	DNAH10	4061	Q8IVF4
SPFINENTRRKFLIY	SEC14L5	436	O43304
ITRQYRKVKAPAAAQ	PRDM2	1696	Q13029
KNRVLQIIPYEFNRV	PTPRA	561	P18433
NPFIYTLRNKEVRET	OR6F1	286	Q8NGZ6
NPIVYAVRTKQIRES	OR52M1	291	Q8NGK5
NRVTPQNERIYLIVK	KIF13A	1241	Q9H1H9
KRNTLNPVYNEAIVF	SYT9	411	Q86SS6
QLPFLLYQVTRKFRD	PARS2	176	Q7L3T8
KVLDIIYQPQAIFRV	NLE1	86	Q9NVX2
IYQPQAIFRVRAVTR	NLE1	91	Q9NVX2
VNQLKPFHRYEIRIQ	USH2A	4596	O75445
LKRIPQAVIDEFYSR	ATP6V1B1	486	P15313
PKFIVDYQTQERERI	TBC1D31	681	Q96DN5
VQYLVLRKDLSQAPF	PTRHD1	26	Q6GMV3
IYKVPQVRVLDFQKV	SNRPA1	136	P09661
IDTPQFQRLRYIKQL	SAMHD1	136	Q9Y3Z3
IQVRFKNLASRPYSL	F5	1656	P12259
ITYNRFQAVTRPIKT	PTAFR	111	P25105
EVQRKEVQARAVFYP	PHF12	786	Q96QT6
RKIYSINEDLVFLRP	PREX1	666	Q8TCU6
DVKVARTLPVAQAYQ	TANC2	1946	Q9HCD6
RNQQSDFYKIPIEIV	STEAP2	241	Q8NFT2
QQIPVFRQKRSDLYA	NIT2	256	Q9NQR4
VVAKYINRFRQAQPT	PROSER3	101	Q2NL68
EYEPAKRFSIRQIRQ	STK11	291	Q15831
RAFKELPVNAQNYVR	ADSS2	416	P30520
RRIIFYSLIKPSINE	SUPV3L1	436	Q8IYB8
FKLSPRVKRIFYQNV	IL9R	291	Q01113
VAVYRAQPVVKASVQ	ITGA2B	476	P08514
DAAVIPIKNNRFYTI	PIP	126	P12273
YILFVRKNAIVVLIP	DIS3	851	Q9Y2L1
TIPFIIRYRKELINN	SRBD1	241	Q8N5C6
SIAYKATVNARPQRV	RPTOR	836	Q8N122
KSTIVRLLFRFYEPQ	ABCB7	511	O75027
RVQILKDYVRQHFPA	ACLY	986	P53396
QPSIAKRYIDQKFVQ	PPP2R5A	176	Q15172
AYRCIRVNKFQRVDP	BTG3	56	Q14201
IIDQRTRQPVQTKFY	BCO1	286	Q9HAY6
ITQKILRDFYRPFNA	CHST15	531	Q7LFX5
LQQTVRKRNFPFYIT	ERVK-25	546	P63136
YVRLKPALQRLDFSV	RETREG3	216	Q86VR2
KTLPIYAEVQRAVLF	RNF212	251	Q495C1
EIFYDLVRQINRKTP	nan	156	A6NIZ1
TRIYLDLPQNFKIFV	RNF14	36	Q9UBS8
RQSFYRNPIKEVVRF	TPTE	256	P56180
VPEKNFRVTAYKAVQ	THRAP3	516	Q9Y2W1
IYQKLTFREVVSPQE	NCAM2	111	O15394
TLYNRIKREPNKFFV	PYGM	586	P11217
FAVIRRASLEKNPYQ	TSPAN32	41	Q96QS1
SIYQRDPLKLVATFR	STAT6	86	P42226
EKPTQIYRFLRTRNL	SUZ12	91	Q15022
ITERANPYFILQRRK	TBC1D9	16	Q6ZT07
SPRYKIIEKRQSVAF	TRBV11-2	26	A0A584
PNFYDTISKIRLRQQ	SMIM19	66	Q96E16
SENVVVRVPQYFKDL	PHEX	336	P78562
VYRADAKEIPRIFQI	ROCK2	1216	O75116
QRIKEILPQYVSAFA	SLFN12	216	Q8IYM2
NPQYLVEKIIRTRIY	PRPF38A	16	Q8NAV1
VQTKFPAYERVVLRE	TJP1	626	Q07157
RRPRSQQYSVLFKQL	ZNF879	181	B4DU55
AIPAAQVILNKYVER	TTC37	961	Q6PGP7
LQQTVRKRNFPFYIT	ERVK-19	551	Q9WJR5
TVIDQVKRFQEIPIY	VWA3B	616	Q502W6
VKRFQEIPIYTISFN	VWA3B	621	Q502W6
QLRFNKPVRYAATVI	SLC5A12	116	Q1EHB4
KEQQKRYFPVFSDRV	SLFN5	371	Q08AF3
VQVLFSIPDFQRKYV	USP5	341	P45974
PLRVLRYVEVFKNSD	TRPV5	641	Q9NQA5
SILNNPIVKARYERF	ZNF326	451	Q5BKZ1
KFVRFQELAVQAPRA	LGI3	501	Q8N145